Low frequency maintenance ganciclovir for cytomegalovirus retinitis

Anthony J.H. Hall, Hector Maclean, Ian D. Jennens, C. Ron Lucas, A. Murray Sandland

Research output: Contribution to journalArticleResearchpeer-review

10 Citations (Scopus)

Abstract

45 patients on maintenance ganciclovir for treated cytomegalovirus (CMV) retinitis were reviewed retrospectively. Treatment was given at 30 mg/kg/week in 3 divided doses: Monday, Wednesday, Friday. The median time to clinical relapse was 5.4 months. This is similar to that reported with higher frequency maintenance regimens. The high degree of immunodeficiency (median CD4 count 16 cells/μl) and poor prognosis (median survival 8.2 months) associated with CMV retinitis were confirmed.

Original languageEnglish
Pages (from-to)43-46
Number of pages4
JournalScandinavian Journal of Infectious Diseases
Volume23
Issue number1
DOIs
Publication statusPublished - 1991
Externally publishedYes

Cite this